Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Das Gupta

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Leukemia Research|February 28, 2007
High dose melphalan or intermediate dose melphalan can be well tolerated and result in good response rates in selected elderly patients with myelomaM Bishton, M Gilyead, E Das Gupta, et al.
British Journal of Haematology|February 26, 2000
Induction of remission after donor leucocyte infusion for the treatment of relapsed chronic idiopathic myelofibrosis following allogeneic transplantation: evidence for a 'graft vs. myelofibrosis' effectJ L Byrne, H Beshti, D Clark, et al.
Bone Marrow Transplantation|June 3, 2014
Extracorporeal photopheresis for treatment of adults and children with acute GVHD: UK consensus statement and review of published literatureE Das-Gupta, F Dignan, B Shaw, et al.
BMC Medical Research Methodology|November 10, 2023
Standardized approach to extract candidate outcomes from literature for a standard outcome set: a case- and simulation studyK M Veen, A Joseph, F Sossi, et al.
The Medical Journal of Malaysia|January 12, 2010
Are Indians and females less tolerant to pain? An observational study using a laboratory pain modelE Das Gupta, A H Zailinawati, A W Lim, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Leukemia Research|February 28, 2007
High dose melphalan or intermediate dose melphalan can be well tolerated and result in good response rates in selected elderly patients with myelomaM Bishton, M Gilyead, E Das Gupta, et al.
British Journal of Haematology|February 26, 2000
Induction of remission after donor leucocyte infusion for the treatment of relapsed chronic idiopathic myelofibrosis following allogeneic transplantation: evidence for a 'graft vs. myelofibrosis' effectJ L Byrne, H Beshti, D Clark, et al.
Bone Marrow Transplantation|June 3, 2014
Extracorporeal photopheresis for treatment of adults and children with acute GVHD: UK consensus statement and review of published literatureE Das-Gupta, F Dignan, B Shaw, et al.
BMC Medical Research Methodology|November 10, 2023
Standardized approach to extract candidate outcomes from literature for a standard outcome set: a case- and simulation studyK M Veen, A Joseph, F Sossi, et al.
The Medical Journal of Malaysia|January 12, 2010
Are Indians and females less tolerant to pain? An observational study using a laboratory pain modelE Das Gupta, A H Zailinawati, A W Lim, et al.
Pageof 2